journal article·2026-07-01

Peptide-Propofol Prodrug with Self-Assembly and Triggered Release for Antidepressant Therapy

Dan Wang, Zihan Yuan, Xianbao Sun, Ling Shen, Yonggui Yuan, Yanpeng Jia, Honghong Yao

ACS Applied Materials & Interfaces· Volume 18· Issue 25
Publisher page

Abstract

Major depressive disorder (MDD) remains difficult to treat with agents that are simultaneously rapid, durable, and well-tolerated. Propofol shows fast antidepressant-like actions but is limited by anesthetic liability, a short half-life, and poor brain-selective exposure. Here, we report Nap-FFYK(propofol), a peptide-propofol self-assembling prodrug engineered to decouple anesthetic burden from sustained antidepressant benefit. Physicochemical characterization confirmed the stimulus-triggered conversion of Nap-FFYK(propofol) to Nap-FFYK and propofol. The prodrug displays high drug loading, robust self-assembly into nanospheres, and carboxylesterase (CES)-responsive release, enabling on-site liberation of propofol with a lower risk of respiratory depression. In the chronic social defeat stress mouse model, a single administration produced rapid and durable antidepressant-like effects with a swift recovery from transient sedation. Mechanistic analyses demonstrated reduced microglial activation, restored astrocytic support, preserved blood-brain barrier integrity, and enhanced synaptic plasticity in hippocampal circuits. These findings validate a targeting-assembly release strategy for propofol repurposing and establish peptide self-assembly prodrugs as a tractable platform for brain-directed, rapid-acting antidepressant therapy. This approach provides a blueprint to pair hour-scale symptom relief with improved safety and durability, addressing key limitations of existing rapid-acting interventions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Chemical Synthesis and Analysis · Neuropeptides and Animal Physiology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Psychiatry and Psychosomatics, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine

Southeast University

State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering

Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine

Institute of Life Sciences, Key Laboratory of Developmental Genes and Human Disease

Funding

Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · Natural Science Foundation of Jiangsu Province · Science and Technology Support Program of Jiangsu Province · Jiangsu Province High-Level Hospital Construction Funds of Zhongda Hospital · National Natural Science Foundation of China (NSFC)

References (48)

Show source-provided references
1. 10.1016/S0140-6736(21)02143-710.1016/S0140-6736(21)02143-7 ↗
2. 10.1016/S2215-0366(21)00251-010.1016/S2215-0366(21)00251-0 ↗
3. 10.1176/appi.ajp.163.1.2810.1176/appi.ajp.163.1.28 ↗
4. 10.1016/S0140-6736(18)31948-210.1016/S0140-6736(18)31948-2 ↗
5. 10.1038/s41467-025-65112-410.1038/s41467-025-65112-4 ↗
6. 10.1002/jev2.1218510.1002/jev2.12185 ↗
7. 10.1038/s41593-017-0010-310.1038/s41593-017-0010-3 ↗
8. 10.1152/ajpcell.00246.202410.1152/ajpcell.00246.2024 ↗
9. 10.1126/science.abb674810.1126/science.abb6748 ↗
10. 10.1038/nn.264710.1038/nn.2647 ↗
11. 10.1038/nprot.2011.36110.1038/nprot.2011.361 ↗
12. 10.1001/archpsyc.63.8.85610.1001/archpsyc.63.8.856 ↗
13. 10.1016/S0006-3223(99)00230-910.1016/S0006-3223(99)00230-9 ↗
14. 10.1038/s41586-023-06624-110.1038/s41586-023-06624-1 ↗
15. 10.1126/science.ado701010.1126/science.ado7010 ↗
16. 10.1038/s41586-025-09755-910.1038/s41586-025-09755-9 ↗
17. 10.1001/jamapsychiatry.2017.008010.1001/jamapsychiatry.2017.0080 ↗
18. 10.1016/S2215-0366(17)30272-910.1016/S2215-0366(17)30272-9 ↗
19. 10.1016/j.bbrc.2024.15027210.1016/j.bbrc.2024.150272 ↗
20. 10.1016/j.ajp.2024.10416710.1016/j.ajp.2024.104167 ↗
21. 10.1001/jama.2018.1275610.1001/jama.2018.12756 ↗
22. 10.1172/JCI12437510.1172/JCI124375 ↗
23. 10.1007/s40263-015-0259-610.1007/s40263-015-0259-6 ↗
24. 10.1016/j.cell.2018.08.03110.1016/j.cell.2018.08.031 ↗
25. 10.1146/annurev-neuro-112723-06203110.1146/annurev-neuro-112723-062031 ↗
26. Vutskits L. · 2025 · 50310.1016/B978-0-323-93273-8.00026-2 ↗
27. 10.1007/s12264-023-01133-710.1007/s12264-023-01133-7 ↗
28. 10.1093/ijnp/pyy08510.1093/ijnp/pyy085 ↗
29. Tadler S. C. · medRxiv · 2023
30. 10.1016/j.neuron.2023.02.01710.1016/j.neuron.2023.02.017 ↗
31. 10.1002/advs.20230905910.1002/advs.202309059 ↗
32. 10.1002/anie.20251703510.1002/anie.202517035 ↗
33. 10.1016/j.celbio.2025.10018410.1016/j.celbio.2025.100184 ↗
34. 10.1021/jacs.2c0574310.1021/jacs.2c05743 ↗
35. 10.1038/s41551-026-01680-010.1038/s41551-026-01680-0 ↗
36. 10.1002/adma.20180579810.1002/adma.201805798 ↗
37. 10.1021/jacs.6b0978310.1021/jacs.6b09783 ↗
38. 10.1002/anie.20181455210.1002/anie.201814552 ↗
39. 10.1002/adma.20230673610.1002/adma.202306736 ↗
40. 10.3969/j.issn.1673-5374.2012.21.00710.3969/j.issn.1673-5374.2012.21.007 ↗
41. 10.5498/wjp.v12.i1.7710.5498/wjp.v12.i1.77 ↗
42. 10.1097/00000539-200210000-0002210.1097/00000539-200210000-00022 ↗
43. 10.1002/adfm.20230393010.1002/adfm.202303930 ↗
44. 10.1002/anie.20240660210.1002/anie.202406602 ↗
45. 10.1021/acsnano.4c1154810.1021/acsnano.4c11548 ↗
46. 10.1016/j.biomaterials.2025.12325410.1016/j.biomaterials.2025.123254 ↗
47. 10.1021/acsnano.4c1011910.1021/acsnano.4c10119 ↗
48. 10.1016/j.bioactmat.2025.08.00410.1016/j.bioactmat.2025.08.004 ↗